| 发明名称 |
MEDICINE CAPABLE OF INHIBITING ACTIVATION OF TRANSCRIPTION FACTOR KLF5 |
| 摘要 |
<p>A medicine capable of inhibiting the activation of transcription factor KLF5 and thus capable of inhibiting blood vessel remodeling and arteriosclerosis, which medicine comprises as an active ingredient an acyclic polyprenyl compound (for example, polyprenylcarboxylic acids such as 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid).</p> |
| 申请公布号 |
WO2005079783(A1) |
申请公布日期 |
2005.09.01 |
| 申请号 |
WO2005JP02986 |
申请日期 |
2005.02.24 |
| 申请人 |
THE UNIVERSITY OF TOKYO;NIKKEN CHEMICALS CO., LTD.;NAGAI, RYOZO;SUZUKI, TORU |
发明人 |
NAGAI, RYOZO;SUZUKI, TORU |
| 分类号 |
A61K31/202;A61K45/00;A61P9/00;A61P9/10;A61P43/00;(IPC1-7):A61K31/202 |
主分类号 |
A61K31/202 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
